Click here to view the United Healthcare (UHC) Medical Policy Updates » March 2025 United…
BCBS Florida Medical Policy Updates – April 2024
Click here to view the Blue Cross Blue Shield BCBS Florida Medical Policy Updates »
April 2024 BCBS Florida Medical Policy Updates:
- Abiraterone Acetate (Yonsa®, Zytiga®) Tablet
- Abrocitinib (Cibinqo®) Tablets
- ADAMTS13 recombinant-krhn (Adzynma) IV Infusion
- Ado-trastuzumab emtansine (Kadcyla™)
- Avacincaptad pegol (Izervay) intravitreal injection
- Bimekizumab (Bimzelx) Injection
- Bio-Engineered Skin and Soft Tissue Substitutes; Amniotic Membrane and Amniotic Fluid
- Biofeedback
- Blood Glucose Monitors and Supplies
- Botulinum Toxins
- Brand Tecfidera®, Diroximel fumarate (Vumerity™), Monomethyl fumarate (Bafiertam) Capsule
- Breast Ductoscopy
- Buprenorphine HCl (Probuphine®) Subdermal Implant and Buprenorphine (Sublocade™) Subcutaneous Injection
- Canakinumab (Ilaris®) Injection
- Cantharidin (Ycanth)
- Cervical Spine Surgery
- Computed Tomography Angiography (CTA) Brain (Head)
- Computed Tomography Angiography (CTA) Lower Extremity
- Computed Tomography Angiography (CTA) Neck
- Computed Tomography Angiography (CTA) Upper Extremity
- Computerized Dynamic Posturography
- Daratumumab (Darzalex®) Infusion and Daratumumab-Hyaluronidase-fihj (Darzalex FasproTM) Injection
- Drugs and Biologics without a Medical Coverage Guideline (Orphan Drugs and Off-Label and Labeled Use of FDA Approved Drugs)
- Ductal Lavage and Suction Collection Systems
- Dupilumab (Dupixent®) Injection
- Electrostimulation and Electromagnetic Therapy for Treating Wounds
- Elranatamab-bcmm (Elrexfio) Subcutaneous Injection
- Emapalumab-lzsg (Gamifant) IV
- Enteral Formulas
- Enzyme Replacement Therapy for Pompe Disease
- Eplontersen (Wainua)
- Eribulin Mesylate (Halaven®) Injection
- Esketamine (Spravato®) Nasal Spray
- Etrasimod (Velsipity) Tablet
- Exagamglogene autotemcel (Casgevy) suspension for IV infusion
- Fam-trastuzumab deruxtecan-nxki injection (Enhertu®)
- Fingolimod (Gilenya™) Capsule
- Foot Care Services
- Fosnetupitant-Palonosetron (Akynzeo) IV
- Genetic Testing
- Glycerol Phenylbutyrate (Ravicti®)
- Granisetron (Sustol®) Injection
- Granulocyte Colony Stimulating Factors
- Hereditary Angioedema Drug Therapy
- Hyperbaric Oxygen Therapy (Systemic & Topical)
- Investigational Services
- Iptacopan (Fabhalta) Capsules
- Levoketoconazole (Recorlev) tablets
- Lifileucel (Amtagvi) suspension for IV infusion
- Lovotibeglogene autotemcel (Lyfgenia) suspension for IV infusion
- Lumasiran (Oxlumo) injection
- Magnetic Resonance Cholangiopancreatography (MRCP)
- Magnetic Resonance Imaging Chest (Thorax)
- Margetuximab-cmkb (Margenza )
- Mastectomy for Gynecomastia
- Mirikizumab (Omvoh) Injection and Infusion
- Multiple Sclerosis Self Injectable Therapy (Interferon beta products, Copaxone and Glatopa)
- Multiple-Gated Acquisition (MUGA) Scan
- Nedosiran (Rivfloza) subcutaneous injection
- Neurolysis/Ablation
- New-To-Market Program for ProviderAdministered Medications
- NK-1 receptor antagonist injectable therapy (Emend®, Cinvanti®)
- Obinutuzumab (Gazyva®) Injection
- Oral Oncology Medications
- Oral Therapy for Gaucher Disease
- Orthotics
- Outpatient Medical Nutrition Therapy
- Partial Left Ventriculectomy and Surgical Ventricular Restoration
- Pegloticase (Krystexxa®) Infusion
- Pertuzumab (Perjeta™) Injection
- Pertuzumab; Trastuzumab; Hyaluronidasezzxf (Phesgo)
- Positive Pressure Ventilation
- Pozelimab-bbfg (Veopoz)
- Prosthetics
- ProThelial™ for the Treatment of Oral Mucositis
- Pulmonary Hypertension Drug Therapy
- Reduction Mammaplasty
- Rilonacept (Arcalyst®) Injection
- Sacituzumab Govitecan-hziy (Trodelvy)
- Secukinumab (Cosentyx ) Injection
- Siponimod (Mayzent®) Tablets
- Sodium Oxybate (Xyrem®) and Calcium, Magnesium, Potassium, and Sodium Oxybates (Xywav®) Oral Solutions
- Sodium Phenylbutyrate (Buphenyl®)
- Step Therapy Requirements for Medicare Outpatient (Part B) Medications
- Talquetamab-tgvs (Talvey) Subcutaneous Injection
- Teprotumumab (Tepezza®) Infusion
- Teriflunomide (Aubagio®) Tablet
- Tetrabenazine (Xenazine) and Deutetrabenazine (Austedo)
- Tocilizumab (Actemra ) Injection and Infusion
- Tralokinumab-ldrm (Adbry®) Injection
- Trastuzumab (Herceptin® , biosimilars) and Trastuzumab and hyaluronidase-oysk (Herceptin Hylecta™) Injection
- Tumor/Genetic Markers
- Valoctocogene Roxaparvovec-rvox (Roctavian)
- Vamorolone (Agamree) Oral Solution
- Vascular Endothelial Growth Factor Inhibitors for Ocular Neovascularization
- Vedolizumab (Entyvio®) Infusion
- Wheelchairs and Wheelchair Accessories
- Zilucoplan (Zilbrysq) Subcutaneous Injection
- Zuranolone (Zurzuvae) Oral Capsules
Click here to view the Blue Cross Blue Shield BCBS Florida Medical Policy Updates »
How Does Policy Alerts Work?
Policy Alerts’ medical policy monitoring and alerts software continuously monitors Commercial, Medicare, and Medicaid coverage information to keep you up-to-date on coverage changes in real-time.
Policy Alerts’ software locates relevant Payer medical policies and coverage information from across the web. This software monitors that information for updates and changes while also searching for new medical policies and coverage information. Whenever changes occur, Policy Alerts immediately sends out an email notification containing a summary of what has changed.
Clients can access their medical policies and payer coverage summary on the interactive Policy Alerts dashboard. Never miss another important insurance carrier medical policy review or coverage decision update again!
✓ Thousands of subscribers ✓ Easy setup
Related Posts
